J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 27, 2022 at 10:42: AM
via Legend Biotech, Johnson & Johnson’s partner on closely watched CAR-T therapy Carvykti, is looking for additional funding as the drug launches and the Chinese biotech's global expansion kicks into gear.

article source
 

<



Similar threads

cafead
J&amp;J’s CAR-T partner Legend Biotech reportedly receives buyout offer
Replies
0
Views
90
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J wows with a $350M cash deal to partner on CAR-T with Legend, a one-time unknown...
Replies
0
Views
204
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AstraZeneca &amp; Aptamer partner to bolster targeted siRNA therapies
Replies
0
Views
28
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J, Rallybio partner on drug development for rare fetal condition
Replies
0
Views
66
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J partner Aspen, with no orders for its COVID shot, warns low demand sends &#039;bad...
Replies
0
Views
115
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote